This site uses cookies, if you continue without changing your settings, we'll assume that you are happy to receive all cookies. Click here to learn how to change your cookie settings.

Continue
Close

Stephen J. Immelt

CEO, Washington, D.C.

Stephen J. Immelt

Stephen J. Immelt is the CEO of Hogan Lovells and divides his time between the firm’s London and Washington, D.C. offices. Prior to taking on this position, Steve served as the Global Co-Head of Hogan Lovells' Litigation and Arbitration practice and as a member of the International Management Committee. Steve has served in a number of other leadership positions during his time at the firm.

Steve’s legal practice has focused primarily on complex enforcement litigation relating to a range of healthcare issues. For more than 20 years, Steve has represented pharmaceutical companies, medical device companies, academic health centers and medical schools, clinical laboratories, and other providers of healthcare in connection with a wide variety of governmental investigations, both civil and criminal in nature, involving issues arising under federal and state laws that govern healthcare providers. These matters have included a wide range of issues arising under the Anti-Kickback Act, the Food Drug and Cosmetics Act, the Foreign Corrupt Practices Act, and the False Claims Act. Steve has particular experience in off-label and financial relationship cases. He has also handled a variety of issues arising from funded research, both in terms of compliance with regulatory requirements governing the use of research funds and allegations of misconduct by researchers.

Steve speaks and writes frequently on healthcare fraud and compliance issues and has been recognized nationally for his expertise in these areas.

Steve served as an Assistant U.S. Attorney for the District of Maryland from 1979 through 1983. During his service in this office, he participated in numerous criminal trials dealing with political corruption, fraud, tax evasion, and conspiracy charges. Steve returned to private practice in 1983 and joined the firm in 1989.